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Behavioral, autonomic, and endocrine outputs of the CNS are subject to important feedback modulation by viscerosensory signals that
are conveyed initially to the hindbrain nucleus of the solitary tract (NST). In the present study, noradrenergic (NA) neurons [i.e., those
that express the NA synthetic enzyme dopamine  hydroxylase (DbH)] in the caudal NST were lesioned to determine their role in
mediating anorexic responses to gastric stimulation and in conveying gastric sensory signals to the hypothalamus and amygdala. For this
purpose, saporin toxin conjugated to an antibody against DbH was microinjected bilaterally into the caudal NST in adult rats. Control rats
received similar microinjections of vehicle. Several weeks later, rats were tested for the ability of systemic cholecystokinin octapeptide
(CCK) (0 or 10g/kg) to inhibit food intake. CCK-induced anorexia was significantly attenuated in toxin-treated rats. Rats subsequently
were used in a terminal cFos study to determine central neural activation patterns after systemic CCK or vehicle and to evaluate lesion
extent. Toxin-induced loss of DbH-positive NST neurons was positively correlated with loss of CCK-induced anorexia. Hypothalamic cFos
expression was markedly attenuated in lesioned rats after CCK treatment, whereas CCK-induced neural activation in the parabrachial
nucleus and amygdala appeared normal. These findings suggest that hindbrain NA neurons are an integral component of brainstem
circuits that mediate CCK-induced anorexia and also are necessary for hypothalamic but not parabrachial or amygdala responses to
gastric sensory stimulation.
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Introduction
Behavioral, autonomic, and endocrine outputs of hypothalamic
and limbic forebrain circuits are subject to important feedback
modulation by viscerosensory signals from the gut, and bi-
directional interactions between gastrointestinal function and
behavioral– cognitive state are well recognized. These interac-
tions contribute to the clinical problem of anorexia after chemo-
therapeutic cancer treatment and may underlie the high comor-
bidity of gastrointestinal disorders with anxiety, depression, and
other psychiatric disorders (Ballenger et al., 2001; Mayer et al.,
2001). However, the neurochemistry and functional organiza-
tion of central pathways between the gut, hypothalamus, and
limbic forebrain are incompletely understood.
Systemic administration of cholecystokinin octapeptide
(CCK) provides a straightforward way to activate central gastric
viscerosensory pathways to study their functional organization.
CCK binds to receptors on gastric vagal afferents, thereby stimu-
lating viscerosensory inputs to the medullary nucleus of the sol-
itary tract (NST) (Raybould et al., 1985; Day et al., 1994; Schwartz
and Moran, 1998). Small doses of CCK in rats and in humans
mimic the physiological satiety effects of endogenous CCK re-
leased from the gut postprandially (Schwartz and Moran, 1998).
Conversely, large doses of CCK (i.e., 10 –100 g/kg) produce
anorexia that generally is accompanied by nausea, pituitary re-
lease of stress hormones, and, in humans, anxiety (Verbalis et al.,
1986a,b; Kamilaris et al., 1992; McCutcheon et al., 1992;
Greenough et al., 1998). Combined radiofrequency lesions of the
area postrema (AP) and portions of the medial NST in rats vir-
tually eliminate the anorexigenic effect of low doses of exogenous
CCK (i.e., 1–2 g/kg) (Edwards et al., 1986). However, these
lesions spared a portion of the caudal medial and commissural
NST, and a higher dose of CCK (i.e., 8g/kg) was still effective in
inhibiting food intake (Edwards et al., 1986).
In rats, systemic CCK activates ascending projections to the
hypothalamus and amygdala that arise primarily from noradren-
ergic (NA) [i.e., dopamine  hydroxylase (DbH) positive] neu-
rons of the A2 cell group, located within the caudal medial and
commissural NST (Rinaman et al., 1995; Myers and Rinaman,
2002). CCK also activates a smaller contingent of noncat-
echolaminergic NST neurons with ascending projections; these
are immunoreactive for glucagon-like peptide 1 (GLP-1) (Rina-
man, 1999; Myers and Rinaman, 2002). Other ascending viscer-
osensory pathways activated by CCK include NST projections
that are relayed through the ventrolateral medulla (VLM) and
pontine parabrachial nucleus (PBN). Ascending NA pathways
are implicated in viscerosensory activation of the hypothalamus
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(Sawchenko and Swanson, 1981; Ueta et al., 1993; Sawchenko et
al., 2000), but the relative contributions of NA and noncat-
echolaminergic projections from the NST to the hypothalamus
and other central viscerosensory circuit components are unclear.
A novel immunotoxin comprising an antibody to the NA syn-
thetic enzyme DbH conjugated to saporin toxin has been used
successfully to selectively destroy hindbrain neurons that contain
DbH (Wrenn et al., 1996; Madden et al., 1999; Ritter et al., 2001;
Fraley et al., 2002; Fraley and Ritter, 2003). The present study
used this toxin to selectively destroy DbH-positive neurons in the
caudal NST and thereby determine their role in mediating the
anorexigenic and CNS activation effects of exogenous CCK.
Materials and Methods
Animals. All procedures conformed to National Institutes of Health
guidelines and were approved by the University of Pittsburgh Animal
Care and Use Committee. Data from 20 adult male Sprague Dawley rats
(Harlan Sprague Dawley, Indianapolis, IN) are included in this report.
Rats were singly housed with ad libitum access to water and pelleted rat
chow (Purina, St. Louis, MO) except during food intake experiments.
Colony rooms were maintained at 22–23°C and kept on a 12 hr light/dark
cycle, with lights on from 7:00 A.M. to 7:00 P.M. Rats weighed 180 –225
gm at the time of toxin injection surgery and 200 –325 gm at the time of
food intake experiments and the terminal cFos study.
Experimental groups. Rats received bilateral injections of anti-DbH–
saporin toxin (toxin; n  10; Advanced Targeting Systems, San Diego,
CA) or 0.15 M NaCl (vehicle; n 10) into the caudal NST. Each rat was
used in a food intake experiment and in a terminal cFos study.
NST microinjection. Toxin or vehicle microinjections were made into
the NST at six sites (Fig. 1). Injection sites encompassed the NST region
that contains the highest incidence of cFos expression by DbH-positive
neurons after CCK treatment, corresponding to the location of the A2
cell group within the caudal medial NST (Sawchenko and Swanson,
1982; Rinaman et al., 1993; Rinaman et al., 1995). Rats were anesthetized
with halothane (2–5% in 100% oxygen) and secured in a stereotaxic
frame using blunt ear bars, with the head ventroflexed. The skin over the
dorsal neck surface was shaved and incised, and the neck muscles were
retracted and bluntly dissected to expose the meninges overlying the
dorsal surface of the caudal medulla. With the aid of a surgical micro-
scope, the meninges were cut with a sterile needle to reveal the AP. Under
visual guidance, a glass micropipette tip (outer diameter of 50 –75 m)
filled with toxin or vehicle and affixed to a 0.5 l Hamilton syringe was
positioned on the midline at the caudal limit of the AP and was then
moved 0.25 mm lateral and 0.5 mm below the medullary surface for the
first, most caudal injection site. The second injection site was located 0.25
mm below the lateral border of the AP at its midrostrocaudal extent, and
the third site was located 0.25 mm below the lateral border of the AP at its
most rostral extent (Fig. 1). The three NST injection sites were then
duplicated contralaterally. At each injection site, 50 nl of sterile 0.15 M
NaCl vehicle containing 0 or 5 ng of toxin was delivered by manual
pressure injection over30 sec. Toxin was freshly prepared from a fro-
zen stock solution within 2 hr of injection. Results from a published
report (Madden et al., 1999) and additional pilot studies confirmed that
this concentration and volume of toxin destroyed the majority of DbH-
positive neurons within the caudal NST (see Results). Lower toxin doses
were less effective, whereas higher doses produced marked tissue necro-
sis. After each microinjection, the pipette tip was left in place for 1–2 min
and then withdrawn. The skin incision was closed with stainless steel clips
after the final injection. Rats were returned to their home cages after
recovery from anesthesia.
The fact that saporin toxin microinjected near NA cell bodies effec-
tively lesions those cells provides empirical evidence for vesicular release
and concomitant extracellular exposure of DbH within the toxin injec-
tion site (Madden et al., 1999). The dorsal vagal complex (DVC) receives
relatively sparse input from other medullary and pontine NA cell groups
but is richly innervated by DbH-positive nerve terminals of presumably
local origin. Somatic and/or dendritic vesicular release from NA neurons
also may occur, as has been reported for local monoamine release within
the locus ceruleus and other central sites (Pudovkina et al., 2001).
Postsurgical maintenance. Rats with NST vehicle injections attained
their presurgical body weights (BWs) within 2–3 d after surgery and
continued to gain BW thereafter (Fig. 2). Conversely, although the 10 rats
with bilateral toxin injections also attained their presurgical BWs within
2–3 d, several began to lose BW beginning 6 –7 d after surgery. This effect
is consistent with the delayed time course of toxin-induced neuronal
death (Madden et al., 1999). To encourage food intake in these rats while
maintaining consistent dietary treatment within both groups, all vehicle-
and toxin-injected rats were given daily overnight access to 25 ml of a
Figure 1. Schematic representation of NST sites (X) targeted for 50 nl microinjections of
toxin or vehicle. Similar contralateral sites were targeted in each rat. Schematics adapted from
commercially available digital files (Paxinos and Watson, 1998). CC, Central canal; py, pyramidal
tract; sol, solitary tract.
Figure 2. Line graph plotting the average body weights of rats at several experimental time
points after bilateral injections of saporin toxin or vehicle into the caudal NST. Toxin-injected
rats weighed14 –17% less than vehicle-injected controls at the time of feeding tests and
terminal cFos studies, respectively. The 2 week period of Ensure liquid diet supplementation for
both groups is indicated by arrows.
Rinaman • NA Lesions Disrupt Central Viscerosensory Circuits J. Neurosci., November 5, 2003 • 23(31):10084 –10092 • 10085
palatable liquid diet (vanilla-flavored Ensure) in addition to ad libitum
chow, regardless of their postsurgical BW profile. Liquid diet access was
initiated 7 d after NST injection surgery and discontinued after 2 weeks,
by which time the majority were consuming their full allotment of liquid
diet plus additional chow each day, and all had surpassed their presurgi-
cal BWs. Rats continued to gain at least 1 gm of BW per day after termi-
nation of liquid diet access. Three toxin-injected rats did not consume
adequate amounts of chow or liquid diet to maintain BW. These rats were
killed without data collection and are not included in the reported n
values.
Food intake experiment. At least 10 d before the terminal cFos experi-
ment described below, rats with bilateral NST injections of toxin (n 10)
or vehicle (n  10) were used to determine the effects on food intake
produced by intraperitoneal administration of CCK. For this purpose,
rats were moved from their original colony room to a new environment
with the same 12 hr light/dark cycle. Rats were housed individually in
clear Plexiglas boxes (25 30 cm floor, 22 cm height) with stainless steel
rod floors, each equipped with a computer-driven pellet delivery and
monitoring system (Med Associates, E. Fairfield, VT). Drinking water
was available ad libitum from sipper tubes within each box. Food access
was restricted to a daily 4 hr period beginning at lights out (7:00 P.M.),
when a single 45 mg chow pellet (Precision Dustless Pellets; Bio-Serv;
Frenchtown, NJ) was delivered automatically to a shallow feeding trough
in each cage, thereby breaking a photobeam crossing the base of the
trough. A new pellet was delivered automatically each time the preceding
pellet was removed. The cumulative number of pellet deliveries (i.e.,
photobeam breaks) was recorded automatically at 15 min intervals dur-
ing the 4 hr feeding period. Cage trays beneath the open rod floors were
routinely inspected at the end of the feeding period to ensure that deliv-
ered pellets were being consumed. Data were collected and stored using
Med PC software (Med Associates). Rats were acclimated to the new
environment and feeding schedule for 1 week before testing, by which
time stable daily 4 hr food intakes were achieved. Rats also were accli-
mated to gentle handling and occasional intraperitoneal saline injections
during this period.
On testing day 1, all rats were injected intraperitoneally with 2.0 ml of
0.15 M NaCl vehicle. Food access was initiated within 2 min, at lights out
(7:00 P.M.). Cumulative pellet delivery data were collected for 4 hr. On
testing day 2, all rats were injected intraperitoneally with 2.0 ml of vehicle
containing CCK (sulfated octapeptide; 10 g/kg BW; Sigma, St. Louis,
MO). Food access was initiated within 2 min after CCK injection, at lights
out (7:00 P.M.). Cumulative pellet delivery data were collected for 4 hr.
Thus, each rat served as its own control for the effects of intraperitoneal
vehicle vs. intraperitoneal CCK treatment on subsequent 4 hr food in-
take. Rats were kept in the same housing environment but were returned
to ad libitum chow access after testing day 2.
Food intake data analysis. BWs ranged from 200 to 293 gm on testing
days; thus, intake (i.e., pellet delivery) data for each rat were converted to
grams (number of pellets  45 mg) and expressed as percentage BW.
Intake data were combined a priori according to NST injection group
(i.e., toxin vs vehicle) and expressed as group mean  SE. Treatment-
related differences in food intake were tested for statistical significance by
using ANOVA, with NST injection plus intraperitoneal treatment (i.e.,
NST toxin or NST vehicle plus intraperitoneal CCK or intraperitoneal
vehicle) as the independent variable. When F values indicated a signifi-
cant main effect of treatment on food intake, the ANOVA was followed
up with post hoc t tests using Dunn’s (Bonferonni) correction for multi-
ple comparisons. Differences were considered significant when p 0.05.
Feeding data in rats with NST toxin injections also were analyzed by
correlating CCK-induced feeding suppression with toxin-induced loss of
DbH-positive neurons (see Results).
CCK-induced cFos experiment. A terminal cFos study was performed in
each rat at least 4 weeks after NST injection surgery and at least 3 d after
the food intake experiment. For this purpose, five rats from each NST
injection group were injected intraperitoneally with 2.0 ml of 0.15 M
NaCl vehicle, and five rats from each group were injected with vehicle
containing CCK (10 g/kg; Sigma). Injections were made between 9:00
A.M. and 10:00 A.M.
Rats were returned to their home cages immediately after intraperito-
neal injection and left undisturbed for 60 –75 min. Rats then were anes-
thetized with sodium pentobarbital (Nembutal; 50 mg/kg, i.p.) and per-
fused through the heart with 0.9% NaCl, followed by fixative solution
(McLean and Nakane, 1974) containing 4% paraformaldehyde, 1.4%
lysine, and 0.2% sodium metaperiodate in 0.1 M sodium phosphate
(buffer). Fixed brains were removed from the skull, postfixed overnight,
and then cryoprotected for 24 – 48 hr in 20% sucrose. A freezing stage
microtome was used to cut coronal sections with a thickness of 30 m
from the caudal extent of the DVC through the rostral extent of the
corpus callosum. Sections were collected in six serially adjacent sets and
stored at20°C in cryopreservant solution (Watson et al., 1986).
Immunocytochemistry. Primary and secondary antisera were diluted in
buffer containing 0.3% Triton X-100 and 1% normal donkey serum.
Dual-immunoperoxidase localization of DbH and cFos was performed
to simultaneously assess the extent of NST lesions and determine
treatment-induced neuronal activation. For this purpose, one of the six
sets of tissue sections from each rat was incubated for 48 hr at 4°C in
rabbit anti-cFos (1:50,000; provided by Dr. P. Larsen, Centre of Clinical
and Basic Research, Laboratory of Obesity Research, Ballerup, Den-
mark). The specificity of this antibody for cFos protein has been reported
previously (Rinaman et al., 1997). Sections were rinsed and processed for
blue– black immunoperoxidase localization of nuclear Fos labeling using
biotinylated donkey anti-rabbit IgG (1:500; Jackson ImmunoResearch,
West Grove, PA), Elite Vectastain avidin– biotin reagents (Vector Labo-
ratories, Burlingame, CA), and a nickel-enhanced DAB reaction. After
cFos immunostaining, sections were incubated for 48 hr at 4°C in mouse
anti-DbH (1:30,000; Chemicon, Temecula, CA) and processed for brown
immunoperoxidase localization of cytoplasmic DbH using biotinylated
donkey anti-mouse IgG (1:500), Elite Vectastain reagents, and a non-
enhanced DAB reaction. Additional sets of tissue sections from each rat
were processed similarly for dual-immunoperoxidase localization of
cFos and calcitonin gene-related peptide (CGRP) (1:20,000; Peninsula
Laboratories, Belmont, CA) or cFos and oxytocin (OT) (1:20,000; Pen-
insula Laboratories). Immunoreacted sections were mounted out of so-
dium phosphate buffer onto charged glass microscope slides (SuperFrost
Plus; Fisher Scientific, Pittsburgh, PA), dehydrated in a graded ethanol
series, defatted in xylene, and coverslipped with Histomount (VWR Sci-
entific, West Chester, PA).
In a selected subset of rats receiving bilateral NST toxin injections and
subsequent CCK treatment before being killed (n  3), additional sets
of tissue sections were processed as described above for dual-
immunoperoxidase localization of cFos plus tyrosine hydroxylase (TH)
(1:50,000; monoclonal antibody; Chemicon) or cFos plus GLP-1
(1:10,000; rabbit polyclonal antibody; Peninsula Laboratories). Immuno-
staining patterns were used to determine whether NST toxin injections de-
stroyed dopaminergic (i.e., TH-positive but DbH-negative) neurons in the
NST and vagal motor nucleus or GLP-1-positive neurons within the NST.
Quantitative analysis of immunolabeling. Cell counting was performed
to document NST lesion extent and treatment-induced cFos expression
in each animal. Counts of DbH-positive neurons in the NST and VLM
were performed bilaterally in every sixth section (180 m frequency)
through the rostrocaudal extent of the AP (four to six tissue sections per
rat; five rats per group). GLP-1 neurons within the caudal NST also were
counted bilaterally in three toxin-injected rats with the most extensive
loss of DbH-positive neurons (see Results). Cells were counted using a
20microscope objective on a Zeiss (Oberkochen, Germany) Axioplan
2 microscope. All DbH- and GLP-1-immunopositive profiles that were
clearly perikaryal (rather than dendritic, axonal, or ambiguous) were
counted, regardless of whether their nucleus was visible in the section.
Overall treatment-induced NST neural activation was determined by
counting cFos-immunopositive profiles within the NST bilaterally in
tissue sections through the rostrocaudal extent of the AP. The proportion
of DbH-positive VLM cells that were colabeled for nuclear cFos was
determined. Cells were considered cFos positive if their nucleus con-
tained detectable blue– black immunolabeling, regardless of labeling in-
tensity and cFos negative if they displayed no visible nucleus or a nucleus
lacking cFos immunolabeling.
An effort was made to standardize the more rostral brainstem and
forebrain regions subjected to quantitative analysis of treatment-induced
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cFos expression. Thus, cFos labeling in the pontine PBN was quantified
by determining the number of CGRP-positive neurons in the lateral PBN
that were activated to express cFos, using counting criteria similar to
those described above. Tissue sections were examined bilaterally through
the rostrocaudal extent of cellular CGRP labeling in the lateral PBN
(three to four sections spaced by 180 m per rat). Activation in the
hypothalamic paraventricular nucleus (PVN) was quantified by deter-
mining the number of magnocellular and parvocellular OT-positive neu-
rons that contained nuclear cFos labeling. In each rat, two tissue sections
through the PVN (spaced by 180 m) containing both medial parvocel-
lular and lateral magnocellular PVN subnuclei were selected for analysis.
Amygdala activation was determined using CGRP fiber immunolabeling
to distinguish the cytoarchitectural boundaries of the central nucleus of
the amygdala (CeA). All cFos-positive profiles within those CeA bound-
aries were counted in tissue sections through the rostrocaudal extent of
fibrous CGRP labeling (five to seven sections spaced by 180 m in each
rat).
Regional cell count data for each rat are expressed as the number of
cells counted in each region bilaterally, divided by the number of ana-
lyzed tissue sections through the region (Table 1). Treatment group data
are expressed as mean SE. Between-group differences in count values
for each region were tested for statistical significance by using ANOVA,
with treatment condition (i.e., NST toxin or NST vehicle plus intraperi-
toneal CCK or intraperitoneal vehicle) as the independent variable.
When F values indicated a significant main effect of treatment on cell
count values, the ANOVA was followed up with post hoc t tests using
Dunn’s (Bonferonni) correction for multiple comparisons. Differences
were considered significant when p 0.05.
Photography and preparation of illustrations. Tissue sections were pho-
tographed using Kodak Ektachrome 160T color slide film (Eastman
Kodak, Rochester, NY). A Polaroid SprintScan 35 slide scanner was used
to import photographic images into Adobe Photoshop 5.0 (Adobe Sys-
tems, San Jose, CA).
Results
The results of this study support the view that NA neurons in the
caudal NST are a necessary component of central circuits that
underlie inhibition of food intake after CCK treatment. NA neu-
rons also appear to be necessary for conveying CCK-related gas-
tric sensory signals to the PVN but appear unnecessary for con-
veying such signals to the lateral PBN and CeA.
NST injection effects on CCK-induced anorexia
Food intake after intraperitoneal vehicle (0.15 M NaCl) treatment
was similar in rats with previous NST injections of vehicle (Fig. 3)
or toxin (Fig. 4). As expected, CCK treatment suppressed food
intake in rats with NST vehicle injections (Fig. 3). Analysis of data
from individual rats confirmed the generality of this effect; that is,
CCK significantly inhibited food intake in every rat within the
Table 1. Individual and group mean cell counts (average per tissue section)
Rat
NST
injection
Intrapentoneal
treatment
NST
#DbH
NST
#cFos
VLM
#DbH; cFos%
Lateral PBN
#CGRPcFos
PVN
#OTcFos
CeA
#cFos
1 Toxin CCK 3.2 172.6 21.5; 4.7% 38.0 5.3 297.4
2 Toxin CCK 11.3 157.7 19.2; 5.2% 42.4 11.3 206.3
3 Toxin CCK 34.8 185.3 28.9; 14.3% 26.5 6.0 192.6
4 Toxin CCK 39.6 194.1 30.0; 10.1% 41.8 4.3 267.8
5 Toxin CCK 41.4 218.4 24.4; 20.8% 30.3 2.6 126.5
Group mean SE 26.1  7.9 185.6  10.2 24.8  3.1; 11.0 3.1% 35.8  3.2 5.9  1.5 218.1  30.0
6 Toxin Vehicle 0.3 39.1 21.9; 5.4% 7.5 9.5 16.3
7 Toxin Vehicle 1.4 12.3 15.7; 13.3% 4.5 7.3 27.8
8 Toxin Vehicle 19.2 15.4 22.2; 4.5% 19.3 5.6 21.2
9 Toxin Vehicle 21.5 22.4 23.0; 0% 11.3 14.2 11.3
10 Toxin Vehicle 52.5 11.3 30.1; 3.3% 2.3 4.3 4.4
Group mean SE 19.0  9.5 20.1  5.1 22.6  2.3; 5.3 2.2% 8.9  3.0 8.2  1.7 16.2  4.0
11 Vehicle CCK 82.7 160.6 35.7/24.7% 41.5 27.5 221.9
12 Vehicle CCK 95.7 174.0 36.5/19.4% 37.5 29.3 142.5
13 Vehicle CCK 108.3 221.3 30.8/20.5% 31.3 48.6 87.8
14 Vehicle CCK 115.0 205.1 43.6/28.0% 48.3 42.4 185.3
15 Vehicle CCK 120.0 263.4 31.4/31.3% 59.6 36.5 204.1
Group mean SE 104.3 6.8 204.9 18.2 35.6 2.3; 24.8 2.8% 43.6 4.9 36.9 4.0 168.3 24.1
16 Vehicle Vehicle 90.0 21.0 32.6/0% 12.5 4.3 8.2
17 Vehicle Vehicle 107.2 9.2 29.6/4.6% 5.3 6.4 13.6
18 Vehicle Vehicle 105.3 9.6 28.4/9.4% 14.6 13.5 29.7
19 Vehicle Vehicle 115.8 18.6 30.5/8.8% 9.5 6.3 24.3
20 Vehicle Vehicle 124.3 3.4 32.5/6.1% 5.3 9.1 17.0
Group mean SE 108.5  5.7 12.4  3.3 30.7  0.8; 5.8 1.7% 9.4  1.9 7.9  1.6 18.6  3.8
Figure 3. Food intake in rats with previous NST vehicle injections (n 10) after control
treatment (0.15 M NaCl) and after CCK (10g/kg). CCK treatment significantly inhibited food
intake at the 30 and 60 min time points (*p  0.05 compared with intake after control
treatment).
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group. The anorexigenic effect of CCK was significant at 30 and
60 min but not at 90 min or later (Fig. 3).
The ability of CCK to inhibit food intake was attenuated in
rats with bilateral NST toxin injections. Group food intake after
CCK treatment was not significantly different from intake after
intraperitoneal vehicle at any time point (Fig. 4). However, the
effects of CCK treatment were variable within this group. Analy-
sis of data from individual rats revealed that CCK inhibited food
intake by15% in six rats with bilateral NST toxin injections but
inhibited food intake by 30 – 60% in the remaining four (see Fig.
6). The ability of CCK to suppress food intake was strongly cor-
related with NA lesion extent, as described below.
Toxin-induced lesions of DbH-immunopositive neurons
Bilateral toxin injections were associated with an average 80%
reduction in DbH-positive NST neurons relative to the average
number of DbH cells per section in rats with NST vehicle injec-
tions (Table 1; Fig. 5, compare A, B). Loss of DbH-positive NST
cells in individual toxin-injected rats ranged from 49.5 to 99.7%
relative to average counts in vehicle-injected rats. These reduc-
tions were significant in every case ( p 0.05). Thus, toxin injec-
tions effectively but variably destroyed DbH-positive NST
neurons.
A toxin-related decrement of DbH-positive caudal VLM neu-
rons also was observed in many rats (Table 1). Toxin-injected rats
displayed an average of 24 DbH-positive VLM neurons per sec-
tion analyzed, significantly fewer than the average 33 cells per
section counted in rats with NST vehicle injections ( p  0.05).
Thus, in addition to destroying DbH-positive NST neurons,
toxin injections often destroyed a subset of DbH-positive VLM
neurons.
Qualitative analysis of TH and GLP-1 immunolabeling in
three lesioned rats with the most complete loss of DbH-positive
NST neurons indicated that the toxin spared dopaminergic neu-
rons in the vagal motor nucleus and caudal NST (Fig. 5C) and
GLP-1-positive peptidergic neurons in the caudal NST (Fig. 5D)
and adjacent reticular formation. The GLP-1 labeling was further
examined quantitatively. The average total number of GLP-1
neurons counted in the three toxin-injected rats (129 5.7 neu-
rons in five to seven tissue sections per rat) was consistent with a
previous report of GLP-1-positive neurons in intact rats (Rina-
man, 1999).
Relationship between extent of NST lesion and
CCK-induced anorexia
As reported above, statistical analysis of group data indicated that
CCK did not significantly inhibit average food intake in rats with
toxin-induced NST lesions (Fig. 4). However, in four rats within
this group, CCK suppressed food intake by28 – 60% relative to
intake after intraperitoneal vehicle treatment (Fig. 6). Postmor-
tem analysis of lesion extent indicated that 33–50% of DbH-
positive NST neurons were spared in these four cases (Table 1,
rats 3–5, 10) relative to average DbH cell counts in nonlesioned
rats. There was a strong positive correlation between the remain-
ing number of NST DbH cells and the magnitude of CCK-
induced anorexia at its maximum extent (i.e., at the 30 min time
point) (Fig. 6).
CCK-induced cFos expression in lesioned and
nonlesioned rats
NST cFos activation was significantly greater in lesioned and
nonlesioned rats after CCK treatment (i.e., range of 158 –263 cells
per section; Table 1) compared with intraperitoneal vehicle (i.e.,
range of 3–39 cells per section; Table 1). On average, somewhat
more NST cFos expression was observed after intraperitoneal
vehicle treatment in rats with toxin lesions (20 cells per section)
compared with cFos in rats without lesions (12 cells per sec-
tion), but this difference was not significant. Average NST cFos
expression was elevated similarly in lesioned and nonlesioned
rats after CCK treatment (i.e., 186 and 205 cells per section, re-
spectively), suggesting that NST toxin lesions eliminated a rela-
tively small subset of the NST neurons activated by CCK (Fig. 5).
In a previous report, CCK administered at a dose of 100 g/kg
activated cFos expression in57% of GLP-1-positive neurons in
intact rats (Rinaman, 1999). The 10-fold lower dose of CCK used
in the present study activated cFos expression in a somewhat
smaller proportion (i.e., 34.8%  7.9) (Fig. 5D) of GLP-1-
positive neurons in the three rats with the most extensive loss of
DbH-positive neurons.
Relatively few cFos-positive neurons were present in the VLM,
lateral PBN, PVN, or CeA in lesioned or nonlesioned rats after
intraperitoneal vehicle (Table 1). After CCK treatment,25% of
DbH-positive VLM neurons were activated in nonlesioned rats,
whereas a significantly smaller proportion (11%) were activated
in lesioned rats ( p 0.05) (Table 1). VLM activation in lesioned
rats after CCK was not significantly different from activation after
intraperitoneal vehicle (Table 1). NST lesions were associated
with even more marked reductions in CCK-induced cFos expres-
sion in the PVN (Fig. 7), including a significant attenuation of
cFos expression by OT-positive neurons (Fig. 8). CCK activated
an average of 37 OT-positive cells per section analyzed in nonle-
sioned rats but only approximately six cells per section in le-
sioned rats (Table 1). These PVN OT activation values were not
significantly different in lesioned rats after CCK treatment com-
pared with OT activation after intraperitoneal vehicle (Table 1).
In contrast to the reduced VLM and PVN activation after CCK
treatment in lesioned rats, CCK-induced cFos expression within
the lateral PBN (Figs. 8, 9) and CeA (Fig. 10) was not attenuated
in lesioned rats (Table 1). Despite a clear loss of DbH-positive
fibers within the lateral PBN (Fig. 9) and CeA (Fig. 10) in lesioned
rats, CCK treatment in lesioned and nonlesioned rats activated
statistically similar numbers of CGRP-positive PBN neurons
(36 and 44 cells per section, respectively) and similar num-
bers of cells within the CGRP-rich region of the CeA (218 and
168 cells per section, respectively) (Table 1).
Figure 4. Food intake in rats with previous NST toxin injections (n  10) after control
treatment (0.15 M NaCl) and after CCK (10g/kg). CCK did not significantly inhibit food intake
at any time point.
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Discussion
Saporin toxin lesion efficacy and specificity
NST microinjections of DbH-saporin toxin conjugate were de-
signed to destroy NA neurons in the caudal medial NST, corre-
sponding to the location of the A2 cell group and the caudal
portion of the C2 cell group. Previous parametric studies attest to
the efficacy and specificity of this toxin conjugate (Wrenn et al.,
1996; Madden et al., 1999; Ritter et al., 2001; Fraley et al., 2002;
Fraley and Ritter, 2003). In the present study, toxin-induced loss
of DbH cell and terminal immunostaining within the caudal
DVC and loss of terminal labeling in the PBN, PVN, and CeA
offers support for lesion efficacy. Although it is possible that the
toxin also destroyed non-DbH-containing neurons, it did not
destroy GLP-1-positive neurons, and it
also left local TH-positive dopaminergic
neurons intact. Furthermore, similar
numbers of cFos-positive NST neurons
were observed in lesioned and nonle-
sioned rats after CCK treatment, consis-
tent with evidence that NA neurons com-
prise a relatively small subset of the total
population of NST neurons activated by
systemic CCK (Rinaman et al., 1993).
A reduced number of DbH-positive
neurons within the VLM was observed in a
subset of toxin-injected rats (Table 1). Be-
cause NA neurons in the VLM are not
known to provide synaptic input to the
caudal NST, their loss may be attributed to
toxin spread from injection sites into the
adjacent reticular formation. However,
VLM NA cell loss did not occur in every
toxin-injected rat and was not necessary
for either attenuation of CCK anorexia or
for suppression of CCK-induced hypotha-
lamic cFos.
A transient baseline anorexia and BW
loss emerged7 d after toxin injections in
many rats but gradually resolved when rats
had access to liquid diet supplement. Spec-
ulatively, dysfunction of NST NA neurons
may disrupt digestive vago-vagal reflexes for which local NA sig-
naling mechanisms are implicated (Rogers et al., 2003), thereby
leading to gastric malaise and/or early satiety. The gradual recov-
ery of BW gain in lesioned rats suggests that compensatory feed-
ing control systems become operational to restore baseline food
intake, despite the loss of NST NA neurons. Indeed, 4 hr food
intake was similar in lesioned and control rats after intraperito-
neal saline injection. Patterns of ad libitum intake were not ana-
lyzed in this study, and it is possible that differences exist between
lesioned and control rats in meal number or size.
Correlation between NA cell loss and CCK-induced anorexia
A strong positive correlation was found between the number of
surviving NA neurons in the caudal NST and the extent of CCK-
induced anorexia. As shown in Figure 6, the greater the loss of
DbH-positive neurons, the more blunted the ability of CCK to
inhibit food intake. A positive correlation between NA neural
activation and feeding-induced gastric distension also has been
reported (Rinaman et al., 1998). Gastric distension inhibits food
intake (Phillips and Powley, 1996), and CCK mimics and ampli-
fies gastric distension vagal afferent signals (Schwartz et al., 1993;
Schwartz and Moran, 1998). Thus, not only are NA neurons in
the caudal medial NST activated by physiological signals that
inhibit food intake, they appear to be necessary for the ability of
exogenous CCK to inhibit food intake.
Although the hypothalamus clearly is involved in food intake
and energy balance (Watts, 2000; Broberger and Hokfelt, 2001;
Berthoud, 2002), it is unclear whether reduced PVN activation in
lesioned rats after CCK treatment is associated with the blunted
anorexigenic response in those rats. CCK does not activate hypo-
thalamic or other forebrain neurons in neonatal rats, but it inhib-
its food intake as early as postnatal day 1 (Rinaman et al., 1994).
CCK also inhibits sucrose intake in adult decerebrate rats that
lack brainstem– hypothalamic connections (Grill and Smith,
1988), and CCK anorexia is preserved in rats after PVN microin-
Figure 5. Color photomicrographs depicting CCK-induced cFos expression (blue– black nuclear label) within the dorsal vagal
complex in a nonlesioned rat (intact; A) and in a rat with a toxin-induced lesion of DbH-positive neurons (B–D are from the same
animal). Tissue sections are double labeled for DbH (A, B), TH ( C), or GLP-1 (D; arrows point out activated neurons). Scale bar in A
applies also to B and C.
Figure 6. Significant positive correlation between the number of DbH-positive NST neurons
remaining in 10 lesioned rats (expressed as percentage of the average number of DbH cells in
nonlesioned rats) and the extent of CCK-induced inhibition of food intake (FI) at the 30 min time
point (expressed as percentage of intake in the same rats after intraperitoneal vehicle injection).
Circled numbers represent individual rats; see Table 1 for cell counting data.
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jection of saporin toxin to remove its NA innervation (Ritter et
al., 2001). In the latter study, 33% of NA neurons were left
intact in the caudal NST, presumably because they do not project
to the PVN toxin injection site. The preserved anorexic response
to CCK in that study is consistent with the correlation data ob-
tained in the present study (Fig. 6).
Considered together, these findings support the view that NA
neurons in the NST are a necessary and integral part of brainstem
circuits that control food intake. These circuits likely include
known NA inputs to regions of the medullary and pontine retic-
ular formation (Day et al., 1997) that contain the central pattern
generators, premotor, and motor neurons that ultimately control
ingestive behavior (Smith, 2000). These integrative and motor
circuits also may include a role for NA neurons in the VLM. A
previous cFos study reported that CCK activates 25% of NA
VLM neurons (Rinaman et al., 1993), similar to the present re-
sults in nonlesioned rats. Conversely, VLM activation was signif-
icantly reduced in lesioned rats after CCK treatment. Because
CCK activates70% of VLM neurons that project to the PVN in
intact rats (Rinaman et al., 1995), the reduced activation of VLM
neurons in lesioned rats also may have contributed to the ob-
served attenuation of PVN cFos expression (discussed further,
below).
A recent report indicates that systemic CCK retains its an-
orexic effects in DbH knock-out mice, in which NA signaling is
absent (Cannon and Palmiter, 2003). It will be important to de-
termine whether toxin-induced loss of DbH-containing neurons
in mice produces effects similar to those observed in the present
study in rats, because there may be a species difference. Alterna-
tively, developmental compensation in DbH knock-out mice
might account for their preserved adult responsiveness to CCK
treatment. However, the most likely explanation for the different
results obtained in the DbH knock-out mouse study and the
present one is that saporin toxin destroys DbH-positive neurons
rather than simply eliminating their NA signaling capacity. NA
neurons also release multiple neuropeptides, and concurrent
elimination of these signaling molecules from central neural cir-
cuits likely contributes to the observed lesion effects.
Dissociation of NA lesion effects on PVN and PBN–CeA
activation after CCK treatment
In addition to inhibiting food intake, systemic CCK increases
plasma levels of stress hormones, including ACTH and OT in rats
(Verbalis et al., 1986a; Kamilaris et al., 1992) and ACTH and AVP
in ferrets, monkeys, and humans (Verbalis et al., 1987; Mi-
askiewicz et al., 1989; Billig et al., 2001). Exogenous CCK also
activates NST NA neurons in ferrets (Billig et al., 2001) and mon-
keys (Schreihofer et al., 1997), as in rats. Plasma hormone levels
were not assayed in the present study, but the blunted PVN cFos
expression observed in lesioned rats after CCK treatment predicts
a similarly blunted or absent stress hormone response, as re-
ported in neonatal rats (Rinaman et al., 1994).
In contrast to the decremented PVN activation in lesioned rats
after CCK, activation in the lateral PBN and CeA apparently was
unaffected. The unexpected dissociation between lesion effects
on the hypothalamus and amygdala suggests that NA neurons in
the caudal NST are unnecessary for conveying gastric viscerosen-
sory signals to the PBN and CeA. Although the CeA receives
direct inputs from the NST that include a prominent NA com-
ponent, the PBN is the main relay for ascending viscerosensory
inputs to the CeA (Saper and Loewy, 1980; Milner et al., 1984;
Herbert et al., 1990; Jia et al., 1994). CGRP provides a distinct
neurochemical marker for the viscerosensory PBN-to-CeA path-
way (Yasui et al., 1989), and this pathway appeared to be activated
normally in lesioned rats after CCK treatment. Although DbH-
Figure 7. Photomicrographs depicting CCK-induced cFos expression (black nuclear label)
within the PVN in a nonlesioned rat (intact; A) and in a rat with a toxin-induced lesion of
DbH-positive neurons (lesioned; B). Tissue sections are double labeled for DbH; note the reduced
PVN cFos expression and DbH fiber labeling in the lesioned rat ( B). Scale bar in A applies also to
B. III, Third ventricle.
Figure 8. Color photomicrographs depicting CCK-induced cFos expression (blue– black nu-
clear label) within the lateral PBN (A, B) and PVN (C, D) in a nonlesioned rat (A and C are from the
same rat) and in a rat with a toxin-induced lesion of DbH-positive neurons (B and D are from the
same rat). Tissue sections through the PBN are double labeled for CGRP (A, B); tissue sections
through the PVN are double labeled for OT (C, D). Arrows point out some of the double-labeled
cells visible in each section. Scale bar in A applies to all panels.
Figure 9. Photomicrographs depicting CCK-induced cFos expression (black nuclear label)
within the lateral parabrachial nucleus (laPBN) in a nonlesioned rat (intact; A) and in a rat with
a toxin-induced lesion of DbH-positive neurons (lesioned; B). Tissue sections are double labeled
for DbH; note the reduced DbH fiber labeling but normally elevated cFos expression in the
lesioned rat ( B). Scale bar in A applies also to B.
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positive NST neurons that project to the PBN and CeA presum-
ably were lesioned, peptidergic NST and AP neurons that project
to the PBN and CeA and do not colocalize DbH (cf. Herbert and
Saper, 1990) presumably were spared. These include projections
arising from GLP-1-positive neurons, which survived the lesions
and were activated after CCK treatment. In this regard, a recent
report indicates that GLP-1 receptor signaling in the CeA con-
tributes to the formation of conditioned taste aversion (CTA), a
sign of nausea, anxiety, and/or visceral illness in rats (Kinzig et al.,
2002). It will be interesting to determine whether NA neurons in
the NST are necessary or dispensable for CTA formation, because
experimental dissociations between the ability of nauseogenic
and anxiogenic stimuli to inhibit food intake and produce CTA
have been reported previously (Curtis et al., 1994; Kinzig et al.,
2002).
Gastric viscerosensory transmission to the hypothalamus and
limbic forebrain
Psychiatrists and gastroenterologists have long appreciated the
functional links between gut and brain. For example, the evolving
disease model for irritable bowel syndrome (IBS) is a self-
perpetuating cycle of positive feedback between the gut and
brain, potentially initiated by pathological events in either the
CNS or enteric nervous system (Mayer, 1999; Ballenger et al.,
2001). Autonomic outputs of the hypothalamus and limbic fore-
brain are thought to contribute to IBS, which leads to altered
viscerosensory feedback from the gut to the brain (Mayer and
Raybould, 1990; Ballenger et al., 2001). Anxiety, depression, and
panic disorder often are comorbid with IBS and are related to
altered neural signaling in the hypothalamus and limbic fore-
brain (Mayer et al., 2001). It will be important to elucidate the
detailed neurochemical and functional organization of neural
pathways that convey gastric viscerosensory signals to these fore-
brain regions. The present results are consistent with the view
that hindbrain NA neurons are critical for conveying gastric vis-
cerosensory signals to the hypothalamus but are unnecessary for
conveying gastric signals to the amygdala. Additional studies are
needed to determine the relative importance of NA and non-NA
pathways in mediating the behavioral and physiological effects
of viscerosensory stimuli under normal and pathological
conditions.
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